Skip to content

Micur-Mic Systems

by Boehringer Mannheim Corp.

PMA P820073

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

PMA P820073↗

FDA record

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA PMA, synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPRL NumberP820073 Date29 Jun 1983DecidedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Generic Name
SYSTEM, TEST, AUTOMATED, ANTIMICROBIAL SUSCEPTIBILITY, SHORT INCUBATION
PMA Number
FDA Product Code
LON
Device Class
Class II
Regulation
21 CFR Part 866.1645
Advisory Committee
Microbiology
FDA Decision
APRL

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Micur-Mic Systems is an Automated Antimicrobial Susceptibility Test System designed for microbiology applications. It automates the determination of antimicrobial susceptibility of microorganisms, enabling rapid and standardized testing with short incubation times to support clinical decision-making in infectious disease management.

This device is intended for use in clinical microbiology laboratories and has received FDA Premarket Approval (PMA). Supplied as a reusable system, it operates under controlled conditions to ensure accurate and reliable antimicrobial susceptibility results. The device adheres to regulatory standards outlined in 21 CFR 866.1645 and is categorized under Class II medical devices.

Other devices from Boehringer Mannheim Corp.

See all devices from Boehringer Mannheim Corp. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Micur-Mic Systems in a clinical setting, and how does it improve workflow efficiency?

    The Micur-Mic Systems automates the determination of antimicrobial susceptibility for microorganisms, enabling faster and more standardized testing with shorter incubation times. This helps clinicians make quicker, data-driven decisions in managing infectious diseases, reducing turnaround time for critical results while maintaining accuracy.

  • Is the Micur-Mic Systems designed for single-use or repeated use in a laboratory environment?

    The Micur-Mic Systems is explicitly described as a reusable device, meaning it is built for repeated use in clinical microbiology laboratories under controlled conditions to ensure consistent and reliable antimicrobial susceptibility testing.

  • What regulatory pathway was followed for the approval of the Micur-Mic Systems, and which federal code governs its classification?

    The Micur-Mic Systems received FDA Premarket Approval (PMA) under the designation P820073, confirming its compliance with regulatory standards. It is classified under 21 CFR 866.1645 and falls under Class II medical devices, as outlined in the submission records.

  • How does the Micur-Mic Systems support clinical decision-making in infectious disease management?

    By automating antimicrobial susceptibility testing, the Micur-Mic Systems provides rapid and standardized results with reduced incubation times. This accelerates diagnostic clarity, allowing clinicians to tailor antibiotic treatments more effectively and efficiently for patients with infectious diseases.